Chicago - Avery Dennison Medical Solutions has introduced a new medical adhesive formulation using polyurethane, which the company says has improved performance over conventional acrylic adhesives and rubber-based dressings.
The Thin Absorbent Skin Adhesive products have a patented adhesive formulation that can be used for a broad range of applications, including wound dressings, backing material for electrodes, ostomy flanges and products for direct wound contact, the company said in a 28 Nov news release.
Avery Dennison's initial offering is MED 5567A, an acrylic-coated polyurethane film on a polyester release liner. Avery said the breathability and high absorbency of the material delivers "superior" fluid handling capacity (FHC) without compromising the benefits that characterise acrylic adhesives.
"The new Thin Absorbent Skin Adhesive platform will redefine market expectations for acrylic adhesives," said Barbara Van Rymenam, global market segment manager, Avery Dennison Medical Solutions.
She added, "The platform has adhesion properties and a moisture vapour transmission rate comparable to traditional acrylic adhesives, but our formulation delivers superior FHC that supports extended wear time. This also helps prevent moisture build-up to minimise skin maceration, which can make skin more susceptible to damage and can delay healing."
Avery Dennison Medical Solutions is a subsidiary of Avery Dennison of Pasadena, California, which has employees in over 60 countries.